| Application no. and date | 19721447.1 (espacenet) (Federated) (European Patent Register), 20190411 | | Patent/reg. no. and date | DK/EP 3774871, 20230628 | | Publication date | 20210217 | | Priority no. and date | US 201862656809 P, 20180412 | | EP pub. no. and date |
EP 3774871 20210217 | | Effective date | | | Applicant/owner | Precision BioSciences, Inc., 302 East Pettigrew Street
Dibrell Building, Suite A-100
Durham, NC 27701, US | | Applicant ref. no. | | | Inventor | SMITH, James, Jefferson, 1916 Weaver Forest Way
Morrisville, NC 27560, US,
LAPE, Janel, 505 Vista Del Lago Lane
Wake Forest, NC 27587, US,
LI, Hui, 2001 Charlion Downs Lane
Apex, NC 27502, US,
GENSCHEL, Jochen, 7913 Broad Street
Raleigh, NC 27613, US | | Representative | | | Opponent | | | IPC Class | A61K 35/17 (2015.01) , A61K 35/76 (2015.01) , A61K 38/46 (2006.01) , A61K 39/00 (2006.01) , C07K 14/725 (2006.01) , C12N 5/0783 (2010.01) , C12N 9/22 (2006.01) | | Title | OPTIMIZED ENGINEERED NUCLEASES HAVING SPECIFICITY FOR THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE | | Int. application no. | US2019027019 | | Int. publication no. | WO2019200122 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
